Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

453 results about "Cyclobutanes" patented technology

Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.

Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.
Owner:PRINCIPIA BIOPHARMA INC

A polymer, a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element

The present invention discloses a liquid crystal alignment agent, including a polyamic acid-polyimide copolymer and an organic solvent. The block polymer in the polyamic acid-polyimide copolymer is prepared by a diamine component comprising a structure shown in the following formula (1) and at least one dianhydride component selected from cyclobutane tetracarboxylic dianhydride shown in the following formula (3-1) and 1,3-dimethylcyclobutane tetracarboxylic dianhydride shown in the following formula (3-2); In formula (1), X1 and X2 each independently represent a single bond or an alkyl group with 1 to 6 carbon atoms; Y1 and Y2 each independently represent one or more of -NHCO-, -CONH-, -OCO-, -COO-; Ar is a nitrogen-containing heterocyclic structure. The present invention can provide a liquid crystal alignment film for a lateral electric field driven liquid crystal display element endowed with high mechanical strength and high transmittance and a liquid crystal display element having the liquid crystal alignment film.
Owner:WUHAN ROUXIAN SCIENCE & TECHNOLOGY CO LTD +2

Curable composition, cured product, adhesive, and sealant

Provided are: a curable composition that has, at high standards, curability, mechanical strength, and low viscosity; a cured product of the same; an adhesive; and a sealant. The curable composition contains an epoxy-oxetane compound represented by chemical formula (I). In the formula, the Rs are the same or different, and each represents a hydrogen atom or a C1-3 alkyl group.
Owner:SHIKOKU CHEM CORP

Halogenated alcohol dehalogenase mutant and synthesis method of chiral gamma-amino alcohol

PendingCN121271831ABacteriaHydrolasesDehalogenaseNucleophile
The invention provides a halohydrin dehalogenase mutant and an application of the halohydrin dehalogenase mutant in synthesis of a chiral gamma-amino alcohol compound. Halogenated alcohol dehalogenase mutants enabling 2-substituted oxetane to be subjected to ring opening are obtained through the technologies of gene mining, directed evolution and the like, and the enzymes can directly perform ring opening on a substrate 2-aryl oxetane under the action of a nucleophilic reagent to generate a series of chiral gamma-amino alcohol compounds which are important precursors for synthesizing drugs. Therefore, the halohydrin dehalogenase mutants have important application value in the industry.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

Polyurethane resin with super-hydrophobic surface and preparation method thereof

The invention discloses polyurethane resin with a super-hydrophobic surface and a preparation method of the polyurethane resin, and belongs to the technical field of modified polyurethane materials. According to the invention, 2, 2 '-diallyl bisphenol A and a fluorine-containing thiol monomer react to introduce a fluorine-containing carbon chain, and then fluorinated modified 2, 2'-diallyl bisphenol A and tetramethoxysilane are used for treating nano zinc oxide, so that the content of active oxygen groups is reduced, a siloxane network structure is formed, the action with water molecules is reduced, and the hydrophobicity is improved. Secondly, the 2, 2 '-diallyl bisphenol A reacts with amino propyl isobutyl POSS to generate a benzoxazine structure, the POSS structure is introduced, the nano-size effect of the benzoxazine structure fills limited movement between molecular chains, a cage-shaped structure serves as a cross-linking point, the mechanical property is improved, and hydrophobicity is achieved. When polyurethane is prepared, 3, 3-bis (hydroxymethyl) azetidine and a benzoxazine structure are subjected to ring opening crosslinking, bonding, dispersity and stability of fluorinated modified nanoparticles and a matrix are enhanced, a complex network structure is formed, the surface roughness is increased, the water contact area is reduced, and super-hydrophobicity is achieved.
Owner:NINGBO HARVEST POLYMER TECH CO LTD

Methods for Treating Immune Thrombocytopenia By Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enentrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Preparation method for carbonaceous material, carbonaceous material and use

PCT designated stage expiredWO2024254753A1Cell electrodesSecondary cellsOctafluorocyclobutaneMetal impurities
The present disclosure relates to the technical field of carbon materials, and particularly relates to a preparation method for a carbonaceous material, the carbonaceous material and a use. A carbonized material formed by a biomass material is sintered at a high temperature in a chlorodifluoromethane atmosphere, and in this process, chlorodifluoromethane is decomposed to generate tetrafluoroethene and hydrogen chloride gas, tetrafluoroethylene can generate octafluorocyclobutane, and octafluorocyclobutane can react with silicon dioxide to generate silicon tetrafluoride, carbon dioxide and carbon; and the generated hydrogen chloride gas can react with metal impurities at a high temperature to generate metal chloride. By means of the preparation method provided by the present disclosure, metal impurities such as iron and calcium can be removed while silicon dioxide is removed, acid pickling and alkali washing processes are not needed, and waste liquid treatment is not involved.
Owner:GUANGDONG BRUNP RECYCLING TECH CO LTD +1

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal element

To provide a liquid crystal alignment agent that yields a liquid crystal alignment film with superior liquid crystal alignment properties, electric characteristics, and mechanical characteristics.SOLUTION: A liquid crystal alignment agent includes: a first polymer including a structural unit (I) derived from a diamine with a moiety represented by formula (1) and a structural unit (T) derived from a substituted cyclobutane tetracarboxylic dianhydride, where the content of the structural unit (T) is 75 mol% or more relative to the total amount of a structural unit derived from a tetracarboxylic acid derivative; and a second polymer including a structural unit (II) derived from a diamine with a moiety represented by formula (2).SELECTED DRAWING: None
Owner:JSR CORPORATION

Treatment of moderate-to-severe asthma by administering rilzabrutinib

PCT designated stage expiredWO2025122747A1Hydroxy compound active ingredientsRespiratory disorderPharmaceutical medicineSevere asthma
Methods for treating patients with moderate-to-severe asthma comprising administering a therapeutically effective amount of at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Synthesis method of 3-oxo-1-cyclobutyl carboxylic acid

The invention discloses a novel method for synthesizing 3-oxo-1-cyclobutanecarboxylic acid, which comprises the following steps: taking dichloroacetyl chloride or trichloroacetyl chloride as a starting raw material, carrying out elimination reaction in a solvent under the catalytic action of alkali or Zn-Cu, and reacting the obtained dichloroketene intermediate with methyl acrylate in situ to generate 3-oxo-2, 2, 3-trimethyl-1-cyclobutanecarboxylic acid, thereby obtaining the 3-oxo-1-cyclobutanecarboxylic acid. The 3-oxo-1-cyclobutanecarboxylic acid is prepared by using 2, 2-dichloro-1-cyclobutanecarboxylic acid as a raw material, then dehalogenation and hydrolysis reactions are carried out to prepare the 3-oxo-1-cyclobutanecarboxylic acid, the 3-oxo-1-cyclobutanecarboxylic acid is a pure product with the content of 99% or above, and the total yield reaches 50% or above. The synthetic route has the advantages of mild conditions, few byproducts, high yield and environmental friendliness, and is suitable for industrial amplification.
Owner:DALIAN RES & DESIGN INST OF CHEM IND

Soft magnetic composite material and preparation method thereof

The invention discloses a soft magnetic composite material and a preparation method thereof, and belongs to the technical field of soft magnetic materials. The preparation method of the soft magnetic composite material comprises the steps that iron, nickel, manganese, aluminum, silicon and chromium are prepared into superfine alloy powder with the D50 particle size ranging from 100 nm to 3000 nm, then the superfine alloy powder reacts with 3-aminopropyltriethoxysilane and tetraethoxysilane firstly and then reacts with cyclobutane tetracarboxylic dianhydride and 3-aminobenzophenone, and the soft magnetic composite material is prepared. The invention discloses a soft magnetic composite material with excellent direct current bias performance and excellent quality factor and a preparation method thereof.
Owner:HANGZHOU XINCHUAN NEW MATERIALS CO LTD

Preparation method of bicyclobutane

The invention provides a preparation method of bicyclobutane, and belongs to the technical field of aerospace fuels. According to the method, the bicyclobutane fuel is efficiently synthesized through nickel-catalyzed bromocyclobutane coupling reaction, and according to the method, nickel chloride serves as a catalyst, a reducing agent manganese powder is added, and the debromination self-coupling reaction of halogenated cyclobutane is promoted. The reduction coupling fuel synthesis strategy shows high efficiency, and the conversion number (TON) of the nickel catalyst can reach 44. The reaction can be carried out in an open system at the temperature of 40 DEG C, a water-free and oxygen-free environment is not needed, the yield of the bicyclobutane fuel is 88%, and the purity of the bicyclobutane fuel is 99% or above. Fuel performance tests show that bicyclobutane has excellent physical and chemical properties, the density is 0.82 g.mL <-1 >, the combustion net heat value is 44.39 MJ.kg <-1 >, and bicyclobutane is a high-energy aerospace fuel with great potential.
Owner:龙子湖新能源实验室

Process of making 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4- methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile and solvate forms thereof

PCT designated stage expiredWO2025029842A8Organic active ingredientsAntipyreticPiperazidinePhenyl group
Disclosed herein are novel methods for preparing 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile, including various solvate forms and intermediates thereof. Also disclosed herein are novel solvate forms and intermediates of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile.
Owner:PRINCIPIA BIOPHARMA INC

Preparation method of octafluorocyclobutane

PendingCN120574109APreparation by halogen additionOctafluorocyclobutaneProcess engineering
The invention relates to a preparation method of octafluorocyclobutane, which comprises the following steps: mixing hexafluorocyclobutene with preheated nitrogen trifluoride, carrying out addition reaction on the mixed gas, and condensing and collecting the octafluorocyclobutane after the reaction is completed. According to the method, octafluorocyclobutane is prepared by using nitrogen trifluoride, continuous production of octafluorocyclobutane with the purity being 99 wt% or above can be achieved, the preparation method has the advantages of being low in raw material cost, simple in process, low in energy consumption, simple in product separation, good in selectivity and convenient to purify, and amplified continuous production can be achieved easily.
Owner:LINGGAS MATERIALS TIANJIN LTD

Curable composition, cured product, adhesive and sealant

The present invention provides a curable composition having high levels of curability, low viscosity, and mechanical strength, as well as a cured product thereof, an adhesive, and a sealant. The curable composition contains an epoxy-oxetane compound represented by chemical formula (I), in which R may be the same or different and represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms. [Formula 1] JPEG0007588753000026.jpg3685
Owner:SHIKOKU CHEM CORP

Azetidine derivative as well as preparation method and application thereof

The invention discloses an azetidine derivative and preparation and application thereof in the field of organic chemistry, the chemical structural general formula III of the azetidine derivative is # imgabs0 #, R1 is one of methyl, ethyl, cyclopropyl, phenyl, substituted phenyl and thiazolyl; r2 is one of hydrogen, methyl and ethyl. According to the present invention, the azetidine derivative has significant antibacterial activity, and can be used for preparation of drugs for treatment of S.aureus, E.coli and MRSA infectious diseases. And meanwhile, the antibacterial agent can also be combined with other antibacterial active substances for use.
Owner:CHONGQING BEAVER HOME NETWORK TECH CO LTD

Pharmaceutically acceptable salts and crystalline forms of GLP-1 receptor agonists and methods for preparing same

The present invention provides a pharma- ceutically acceptable salt of a GLP-1 receptor agonist, a crystalline form thereof, and a method for preparing the same. Specifically, the present invention provides a pharma- ceutically acceptable salt of the compound 2-((4-((S)-3-(4-chloro-2-fluorophenyl)-2,3-dihydrobenzo[b][1,4]dioxan-5-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid and a crystalline form thereof.
Owner:JIANGSU HENGRUI MEDICINE CO LTD +1

Rubber formulations comprising statistical copolymer comprising vinylbenzocyclobutane

To provide rubber formulations that do not require the addition of curing agents, thereby reducing costs and improving sustainability.SOLUTION: Embodiments of the present disclosure are directed to rubber formulations, wherein the formulations include a statistical copolymer. The statistical copolymer includes a polymerized, crosslinkable reaction product derived from a conjugated diene monomer and vinylbenzocyclobutane. The rubber formulation is substantially free of traditional rubber curing agents.SELECTED DRAWING: Figure 1
Owner:BRIDGESTONE CORP +1

Synthetic method of 3-aminooxetane-3-formic acid

The invention belongs to the field of medicine synthesis, and relates to a synthesis method of a medicine intermediate 3-aminooxetane-3-formic acid. The method has the advantages of cheap and easily available raw materials, non-toxic intermediate products and high yield of final products, and has industrial production prospects.
Owner:CHANGSHA HANCHEN BIOTECHNOLOGY CO LTD

Synthesis method of 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane

The invention provides a synthesis method of 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane (EGMO), and belongs to the technical field of fine chemical engineering. According to the method, sodium hydroxide is taken as an alkaline reagent, and a quaternary ammonium salt or quaternary phosphonium salt phase transfer catalyst is adopted to promote the effective contact of sodium salt and epichlorohydrin, so that the conversion process of preparing 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane from 3-ethyl-3-oxetane and epichlorohydrin is catalyzed. According to the method disclosed by the invention, the EGMO is synthesized by dropwise adding the epoxy chloropropane through a one-pot method, and a product with relatively high content and relatively low color number can be obtained without distillation, so that the reaction time is shortened, the side reaction of the epoxy chloropropane is reduced, the production efficiency, the product yield and the purity are improved, and the color number of the product is reduced. The preparation process is convenient to operate, simple and suitable for industrial production.
Owner:HUBEI JINGHONG CHEM CO LTD

Novel polyimide

The invention provides novel polyimide. Aliphatic bio-based polyimide is synthesized through a salt monomer method. The preparation method comprises the following specific steps: 1) respectively dissolving cyclobutanetetracarboxylic acid (CBTA) and NH2 (CH2) nNH2 (n = 2, 3, 4... 20) in an organic solvent, and stirring to obtain a solution; 2) mixing the two different solutions, and separating out ion pairs to obtain corresponding crystals; and 3) carrying out thermal polymerization on the salt monomer to obtain the aliphatic polyimide. The novel polyimide is prepared through the green, environment-friendly, simple and efficient synthesis method, and the application prospect is wide.
Owner:JIANGNAN UNIV

Spiro butane indolone derivative as well as preparation method and application thereof

The invention provides a spiro butane indolone derivative as well as a preparation method and application thereof, and belongs to the technical field of organic chemical synthesis. The series cyclization coupling reaction of the N-iodo aryl dicyclobutyl amide compound and the vinyl pyridine compound is realized by utilizing a photocatalytic system, and the method is used for constructing the spiro butane indolone derivative containing the pyridine structure. The spirobutane indolone derivative synthesized by the invention has an inhibition effect on H1975 human lung adenocarcinoma cells; the preparation method provided by the invention is mild in condition and simple and convenient to operate, has economical steps, provides a convenient synthesis way for the complex bioactive molecules, and has a good application prospect.
Owner:GUANGDONG MEDICAL UNIV

Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Organic compound, organic light-emitting device and display panel

The invention relates to an organic compound, an organic light-emitting device and a display panel. The organic compound has a structural formula as shown in a formula (1): # imgabs0 #. The organic compound provided by the invention contains tetrahydrocyclobutane dipyrroletetraone, so that the organic compound has an excellent tetrahydrocyclobutane dipyrroletetraone structure with a non-conjugated plane connection design; the organic compound provided by the invention has a relatively high first singlet excited state energy level and a relatively high glass transition temperature; the reasonable introduction of the trifluoromethyl group can make the material have a low refractive index; in addition, when a film layer formed by the organic compound is combined with a high-refractive-index film layer to form a covering layer and the covering layer is applied to the organic light-emitting device, the light-emitting efficiency and the color purity of the device can be remarkably improved, and the problem of visual deviation can be solved.
Owner:GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD

Semi-aromatic CPI film and preparation method thereof

The invention relates to the technical field of flexible display materials, in particular to a semi-aromatic CPI film and a preparation method thereof. The invention relates to a semi-aromatic CPI film. The semi-aromatic CPI film is prepared by carrying out polymerization reaction on alicyclic dianhydride and diamine, the diamine comprises a diamine containing trifluoromethyl, a diamine containing benzimidazole and a diamine containing vinyl phenoxy; the alicyclic dianhydride comprises one or two of norbornane-2-spiro-alpha-cyclopentanone-alpha '-spiro-2'-norbornane-5, 5 ', 6, 6'-tetracarboxylic dianhydride and cyclobutane tetracarboxylic dianhydride, and the alicyclic dianhydride comprises one or two of norbornane-2-spiro-alpha-cyclopentanone-alpha '-spiro-2'-norbornane-5, 5 ', 6, in order to solve the problem that application of an existing polyimide film in a flexible substrate is limited due to the fact that optical properties, high temperature resistance, mechanical properties and dimensional thermal stability of the existing polyimide film are difficult to consider, the temperature resistance, the dimensional stability and the mechanical properties are enhanced while the optical properties of colorless transparent polyimide are kept, and the application prospect is wide. And the application of the flexible display substrate in the field of flexible display substrates is widened.
Owner:SUZHOU ZUNER PHOTOELECTRIC TECH CO LTD

Methods for treating sickle cell disease by administering a BTK inhibitor

Methods for treating Sickle Cell Disease (SCD) comprising administering a BTKi, such as at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof, are disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Crystalline forms of GLP-1 receptor agonists and methods for preparing same

A crystalline form of a GLP-1 receptor agonist and a method for its preparation, wherein the agonist is the compound 2-((4-((S)-3-(4-chloro-2-fluorophenyl)-2,3-dihydrobenzo[b][1,4]dioxan-5-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid.
Owner:JIANGSU HENGRUI MEDICINE CO LTD +1

Low Tg multi-tether copolymerized diblock copolymers for directed self-assembly

Disclosed are two different groups of block copolymers having the general structure (I) or (III), compositions thereof, and methods of using these compositions in DSA; wherein the B fragment and the B1 fragment are polar block copolymer fragments comprising a 2-methylene alkanoic acid alkyl ester-derived repeat unit, a lactone-derived repeat unit, an ethylene oxide-derived repeat unit, an oxetane or cyclic carbonate-derived repeat unit; l and L1 are a direct valence bond or a linking moiety derived from 1, 1-diarylethene; fragments A and A1 are non-polar block copolymer fragments comprising styrenic repeat units, E ', E' ', E3 and E4 are different types of end groups, A2 is a block fragment derived from an olefinic hydrocarbon or diene having a Tg of from about-5 DEG C to about-50 DEG C, and in structure (I), is multi-linked by an oligomeric flexible tether group at different positions as summarized: E'-A-L-B-E ''(I) E3-A1-A2-L1-B1-E4 (III).
Owner:MERCK PATENT GMBH